Lyme borreliosis

European Handbook of Dermatological Treatments, Third Edition

Volumn , Issue , 2015, Pages 561-566

  Hercogova, Janá ^a  

^a UNIVERSITY HOSPITAL BULOVKA   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84944550286     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-662-45139-7_56     Document Type: Chapter

References (24)

1. Aberer E, Keldorfer M, Binder B, Shauperl H. The outcome of Lyme borreliosis in children. Wien Klin Wochenschr. 1999; 111(22-23): 941-4.
2. Arnez M, Radsel-Medvescek A, Pieterski-Rigler D, et al. Comparison of cefuroxime axetil and phenoxymethyl penicillin for the treatment of children with solitary erythema migrans. Wien Klin Wochenschr. 1999; 111(22-23): 916-22.
3. Biesiada G, Czepiel J, Leśniak MR, Garlicki A, Mach T. Lyme disease review. Arch Med Sci. 2012; 8(6): 978-82.
4. Cunha BA. Minocycline versus doxycycline in the treatment of Lyme neuroborreliosis. Clin Infect Dis. 2000; 30(1): 237-8.
5. Dotevall I, Hagberg I. Adverse effects of minocycline versus doxycycline in the treatment of Lyme neuroborreliosis. Clin Infect Dis. 2000; 30(1): 410-1.
6. Eriksson P, Schröder MT, Niiranen K, Nevanlinna A, Panelius J, Ranki A. The many faces of solitary and multiple erythema migrans. Acta Derm Venereol. 2013; 93(6): 693-700.
7. Gilmore Jr RD, Mbow ML. Conformational nature of the Borrelia burgdorferi B31 outer surface protein C protective epitope. Infect Immun. 1999; 67(10): 5463-9.
8. Hayney MS, Grunske MM, Boh LE. Lyme disease prevention and vaccine prophylaxis. Ann Pharmacother. 1999; 33: 723-9.
9. Hercogova J, Brzonova I. Lyme disease in central Europe. Curr Opin Infect Dis. 2001; 14: 133.
10. Hercogová J, Vaňousová D. Syphilis and borreliosis during pregnancy. Dermatol Ther. 2008; 21(3): 205-9.
11. Khatchikian CE, Nadelman RB, Nowakowski J, Schwartz I, Wormser GP, Brisson D. Evidence for strain-specific immunity in patients treated for early Lyme disease. Infect Immun. 2014; 82: 1408-13.
12. Klempner MS, Baker PJ, Shapiro ED, Marques A, Dattwyler RJ, Halperin JJ, Wormser GP. Treatment trials for post-Lyme disease symptoms revisited. Am J Med. 2013; 126(8): 665-9.
13. Maraspin V, Lotric-Furlan S, Cimperman J, et al. Erythema migrans in the immunocompromised host. Wien Klin Wochenschr. 1999; 111(22-23): 923-32.
14. Moniuszko A, Pancewicz S, Czupryna P, Dunaj J, Guziejko K, Zajkowska J. Erythema migrans as a patognomic symptom of Lyme disease [Article in Polish]. Pol Merkur Lekarski. 2013; 35(208): 230-2.
15. Mullegger RR, Glatz M. Is serological follow-up useful for patients with cutaneous Lyme borreliosis? Curr Probl Dermatol. 2009; 37: 178-82.
16. Oksi J, Marjamaki M, Nikoskelainen J, Viljanen MK. Borrelia burgdorferi detected by culture and PCR in clinical relapse of disseminated Lyme borreliosis. Ann Med. 1999; 31(3): 225-32.
17. Pícha D, Moravcová L, Vaňousová D, Hercoogvá J, Blechová Z. DNA persistence after treatment of Lyme borreliosis. Folia Microbiol (Praha). 2014; 59: 115-25.
18. Roupakias S, Mitsakou P, Nimer AA. Tick removal. J Prev Med Hyg. 2011; 52(1): 40-4.
19. Seltyer EG, Gerber MA, Cartter ML, et al. Long-term outcomes of persons with Lyme disease. JAMA. 2000; 283(5): 609-16.
20. Shadick NA, Phillips CB, Sangha O, et al. Musculoskeletal and neurologic outcomes in patients with previously treated Lyme disease. Ann Intern Med. 1999; 131(12): 919-26.
21. Stanek G, Breier F, Menyinger G, et al. Erythema migrans and serodiagnosis by enzyme immunoassay and immunoblot with three Borrelia species. Wien Klin Wochenschr. 1999; 111(22-23): 951-6.
22. Wahlberg P. Vaccination against Lyme borreliosis. Ann Med. 1999; 31: 233-5.
23. Warshafsky S, Nowakowski J, Nadelman RB, et al. Efficacy of antibiotic prophylaxis for prevention of Lyme disease. J Gen Intern Med. 1996; 11: 329-33.
24. Wormser GP, Daniels TJ, Bittker S, Cooper D, Wang G, Pavia CS. Failure of topical antibiotics to prevent disseminated Borrelia burgdorferi infection following a tick bite in C3H/HeJ mice. J Infect Dis. 2012; 205(6): 991-4.